Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected

ObjectiveSepsis is one of the leading causes of the deaths in hospitals. During sepsis, patients are exposed to endotoxemia, which may contribute to the dysregulation of the immune system frequently observed in sepsis. This dysregulation leads to impaired pro-inflammatory responses and may increase...

Full description

Bibliographic Details
Main Authors: Alexandra Brinkhoff, Annette Sieberichs, Harald Engler, Sebastian Dolff, Sven Benson, Johannes Korth, Manfred Schedlowski, Andreas Kribben, Oliver Witzke, Benjamin Wilde
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.01133/full
id doaj-845bf62b6bcf4e4bac64637ce6be6359
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Alexandra Brinkhoff
Alexandra Brinkhoff
Annette Sieberichs
Annette Sieberichs
Harald Engler
Sebastian Dolff
Sven Benson
Johannes Korth
Manfred Schedlowski
Andreas Kribben
Oliver Witzke
Benjamin Wilde
spellingShingle Alexandra Brinkhoff
Alexandra Brinkhoff
Annette Sieberichs
Annette Sieberichs
Harald Engler
Sebastian Dolff
Sven Benson
Johannes Korth
Manfred Schedlowski
Andreas Kribben
Oliver Witzke
Benjamin Wilde
Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected
Frontiers in Immunology
systemic inflammation
T-cells
IL-17A
IFNγ
Treg
IL-10
author_facet Alexandra Brinkhoff
Alexandra Brinkhoff
Annette Sieberichs
Annette Sieberichs
Harald Engler
Sebastian Dolff
Sven Benson
Johannes Korth
Manfred Schedlowski
Andreas Kribben
Oliver Witzke
Benjamin Wilde
author_sort Alexandra Brinkhoff
title Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected
title_short Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected
title_full Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected
title_fullStr Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected
title_full_unstemmed Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected
title_sort pro-inflammatory th1 and th17 cells are suppressed during human experimental endotoxemia whereas anti-inflammatory il-10 producing t-cells are unaffected
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2018-05-01
description ObjectiveSepsis is one of the leading causes of the deaths in hospitals. During sepsis, patients are exposed to endotoxemia, which may contribute to the dysregulation of the immune system frequently observed in sepsis. This dysregulation leads to impaired pro-inflammatory responses and may increase the risk for secondary infections in sepsis. The experimental human endotoxemia model is widely used as a model system to study the acute effects of endotoxemia. Under physiological circumstances, the immune system is tightly regulated. Effector T-cells exert pro-inflammatory function and are restrained by regulatory T-cells (Tregs), which modulate pro-inflammatory effector responses. Endotoxemia may induce inadequate Treg activity or render effector T-cells dysfunctional. It was the aim of the study to investigate effector T-cell and Treg responses in an experimental human endotoxemia model.MethodsIn a cross-over designed placebo-controlled study, 20 healthy male volunteers received an intravenous injection of either lipopolysaccharide (LPS) (0.8 ng/kg body weight) or a placebo (saline 0.9%). CD3+ T-cells, CD4+ T-cells, CD8+ T-cells, and intracellular cytokine profiles were measured with flow cytometry at baseline and at repeated points after LPS/placebo injection. Complete blood cell counts were obtained with an automated hematology analyzer and cytokines were quantified by ELISA.ResultsCirculating neutrophils were significantly increased 2 h after LPS injection (p < 0.001) while absolute number of CD3+ T-cells, CD4+ T-cells, and CD8+ T-cells decreased (p < 0.001). Effector T-helper-cells (THs) showed a significant—but transient—decrease of pro-inflammatory IFNγ, interleukin (IL)-2, TNFα, and IL-17A production after LPS injection (p < 0.001). In contrast, the frequency of Treg and the capacity to produce IL-10 were unchanged (p = 0.21).ConclusionEffector THs fail to produce pro-inflammatory Th1-/Th17-associated cytokines after LPS challenge. In contrast, IL-10 production by Treg is not affected. Thus, endotoxemia-induced suppression of pro-inflammatory THs might be considered as a contributing factor to immunoparalysis in sepsis.
topic systemic inflammation
T-cells
IL-17A
IFNγ
Treg
IL-10
url https://www.frontiersin.org/article/10.3389/fimmu.2018.01133/full
work_keys_str_mv AT alexandrabrinkhoff proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected
AT alexandrabrinkhoff proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected
AT annettesieberichs proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected
AT annettesieberichs proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected
AT haraldengler proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected
AT sebastiandolff proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected
AT svenbenson proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected
AT johanneskorth proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected
AT manfredschedlowski proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected
AT andreaskribben proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected
AT oliverwitzke proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected
AT benjaminwilde proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected
_version_ 1725816035694608384
spelling doaj-845bf62b6bcf4e4bac64637ce6be63592020-11-24T22:08:33ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-05-01910.3389/fimmu.2018.01133362638Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are UnaffectedAlexandra Brinkhoff0Alexandra Brinkhoff1Annette Sieberichs2Annette Sieberichs3Harald Engler4Sebastian Dolff5Sven Benson6Johannes Korth7Manfred Schedlowski8Andreas Kribben9Oliver Witzke10Benjamin Wilde11Department of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyDepartment of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyDepartment of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyDepartment of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyDepartment of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyDepartment of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyDepartment of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyObjectiveSepsis is one of the leading causes of the deaths in hospitals. During sepsis, patients are exposed to endotoxemia, which may contribute to the dysregulation of the immune system frequently observed in sepsis. This dysregulation leads to impaired pro-inflammatory responses and may increase the risk for secondary infections in sepsis. The experimental human endotoxemia model is widely used as a model system to study the acute effects of endotoxemia. Under physiological circumstances, the immune system is tightly regulated. Effector T-cells exert pro-inflammatory function and are restrained by regulatory T-cells (Tregs), which modulate pro-inflammatory effector responses. Endotoxemia may induce inadequate Treg activity or render effector T-cells dysfunctional. It was the aim of the study to investigate effector T-cell and Treg responses in an experimental human endotoxemia model.MethodsIn a cross-over designed placebo-controlled study, 20 healthy male volunteers received an intravenous injection of either lipopolysaccharide (LPS) (0.8 ng/kg body weight) or a placebo (saline 0.9%). CD3+ T-cells, CD4+ T-cells, CD8+ T-cells, and intracellular cytokine profiles were measured with flow cytometry at baseline and at repeated points after LPS/placebo injection. Complete blood cell counts were obtained with an automated hematology analyzer and cytokines were quantified by ELISA.ResultsCirculating neutrophils were significantly increased 2 h after LPS injection (p < 0.001) while absolute number of CD3+ T-cells, CD4+ T-cells, and CD8+ T-cells decreased (p < 0.001). Effector T-helper-cells (THs) showed a significant—but transient—decrease of pro-inflammatory IFNγ, interleukin (IL)-2, TNFα, and IL-17A production after LPS injection (p < 0.001). In contrast, the frequency of Treg and the capacity to produce IL-10 were unchanged (p = 0.21).ConclusionEffector THs fail to produce pro-inflammatory Th1-/Th17-associated cytokines after LPS challenge. In contrast, IL-10 production by Treg is not affected. Thus, endotoxemia-induced suppression of pro-inflammatory THs might be considered as a contributing factor to immunoparalysis in sepsis.https://www.frontiersin.org/article/10.3389/fimmu.2018.01133/fullsystemic inflammationT-cellsIL-17AIFNγTregIL-10